REKLAMA
BADANIE

KRKA: Acquisition of treasury shares

2026-05-04 13:32
publikacja
2026-05-04 13:32
Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. Detailed report on acquisition of treasury shares_20260424_20260430.pdf

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No

23

/

2026

Date of issue:

2026-05-04

Short name of the issuer

KRKA

Subject

Acquisition of treasury shares

Official market - legal basis

Unofficial market - legal basis

Contents of the report:

Based on the provisions of the Rules of the Ljubljana Stock Exchange, d. d., Ljubljana and Article 2 of the Commission Delegated Regulation (EU) 2016/1052 Krka, d. d., Novo mesto announces:

With a reference to the public notice from 20 July 2023, Krka is publicly disclosing information on transactions relating to buy-back programme in the period from 24 April 2026 up to and including 30 April 2026. Krka acquired 3,332 treasury shares in the total value of EUR 810,672 the Ljubljana Stock Exchange as follows:

- on 24 April 2026: 862 shares at a VWAP of EUR 243.64,

- on 28 April 2026: 854 shares at a VWAP of EUR 243.37,

- on 29 April 2026: 762 shares at a VWAP of EUR 243.04 and

- on 30 April 2026: 854 shares at a VWAP of EUR 243.12.

Price is calculated as volume weighted average price (VWAP).

Ilirika d.d., Intercapital d.d. and NLB d.d. were brokers in these transactions. Detailed report on acquisition of treasury shares attached.

The total number of treasury shares prior to these transactions was 2,509,267 representing 7.652% of all shares issued.

The total number of treasury shares after these transactions is 2,512,599 representing 7.662% of all shares issued.

The notice will be published on the Company's website (www.krka.biz) from 4 May 2026 onwards, for a minimum period of 5 years.

Annexes

File

Description

Detailed report on acquisition of treasury shares_20260424_20260430.pdf

Detailed report on acquisition of treasury shares

KRKA, TOVARNA ZDRAVIL D.D.

(fullname of the issuer)

KRKA

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification

of the WSE in Warsow)

8501

Nove Mesto

(post code)

(city)

Smarjeska

6

(street)

(number)

+386 7 331 21 11

+386 7 332 15 37

(phone number)

(fax)

(e-mail)

(web site)

nie dotyczy

(NIP)

(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date

Name

Position / Function

Signature

Źródło:Komunikaty spółek (ESPI)
Tematy
Konto firmowe za 0 zł plus odsetki. Sprawdź oferty, które wyróżniają się na rynku
Konto firmowe za 0 zł plus odsetki. Sprawdź oferty, które wyróżniają się na rynku

Komentarze (0)

dodaj komentarz

Powiązane:

Polecane

Najnowsze

Popularne

Ważne linki